Xenon Pharmaceuticals Inc. — Institutional Ownership

Which tracked institutions hold XENE, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

30
Funds holding
$1390830914
Total value held
Buying
25 added/new · 5 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $454057014 7522482 +1882364 +33.37%
2 Janus Henderson Group Plc $242858453 4175982 +4175982 NEW BUY
3 Jpmorgan Chase & Co $157381859 2617360 +693750 +36.07%
4 State Street Corp $118885244 1969629 +249096 +14.48%
5 Franklin Resources Inc $86780296 1437712 +157135 +12.27%
6 Invesco Ltd. $54532726 903458 +903458 NEW BUY
7 Federated Hermes, Inc. $53342365 883737 +883737 NEW BUY
8 Goldman Sachs Group Inc $46696005 773625 +3750 +0.49%
9 Northern Trust Corp $40535724 671566 +143783 +27.24%
10 Bank Of New York Mellon Corp $25442801 421518 +25380 +6.41%
11 Morgan Stanley $24521693 406257 -67502 -14.25%
12 Bank Of America Corp /De/ $24389483 404067 +138800 +52.32%
13 Ameriprise Financial Inc $19227556 318548 +318548 NEW BUY
14 Wells Fargo & Company/Mn $10499320 173945 +58293 +50.40%
15 Sei Investments Co $7197547 119251 +4870 +4.26%
16 Citigroup Inc $5560604 92124 +84763 +1151.51%
17 Raymond James Financial Inc $5218787 86461 -2137 -2.41%
18 Royal Bank Of Canada $5129000 84971 -5416 -5.99%
19 Prudential Financial Inc $2378184 39400 +26390 +202.84%
20 Ubs Group Ag $1705230 28251 +28251 NEW BUY
21 Barclays Plc $1209978 20046 -218163 -91.58%
22 Stifel Financial Corp $992434 16442 +16442 NEW BUY
23 Pnc Financial Services Group, Inc. $525193 8701 +604 +7.46%
24 Allstate Corp $493745 8180 +8180 NEW BUY
25 Blackstone Inc. $459219 7608 +7608 NEW BUY
26 Principal Financial Group Inc $453062 7506 +1262 +20.21%
27 Citizens Financial Group Inc/Ri $319365 5291 +328 +6.61%
28 Zions Bancorporation, National Association /Ut/ $20945 347 +347 NEW BUY
29 Us Bancorp \De\ $15573 258 -14 -5.15%
30 First Horizon Corp $1509 25 +25 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.